Access to medicines during the COVID-19 pandemic. The role of The Medicines Patent Pool

Greg Martin discusses the Medicines Patent Pool, a global health organization that improves access to essential medicines in low and middle-income countries. The Pool facilitates licensing agreements between patent holders and generic manufacturers, reducing drug prices and increasing availability. The model has proven successful, saving $1.6 billion and supplying 15 billion doses. The Medicines Patent Pool is also addressing COVID-19, ensuring affordable therapeutics reach underserved regions.

What new insight or understanding did you gain from this video?